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ABSTRACT
Translation initiation in Coxsackievirus B3 (CVB3)
occurs via ribosome binding to an internal ribosome
entry site (IRES) located in the 5¢-untranslated
region (UTR) of the viral RNA. This unique mechan-
ism of translation initiation requires various trans-
acting factors from the host. We show that human
La autoantigen (La) binds to the CVB3 5¢-UTR and
also demonstrate the dose-dependent effect of exo-
genously added La protein in stimulating CVB3
IRES-mediated translation. The requirement of La
for CVB3 IRES mediated translation has been fur-
ther demonstrated by inhibition of translation as a
result of sequestering La and its restoration by exo-
genous addition of recombinant La protein. The
abundance of La protein in various mouse tissue
extracts has been probed using anti-La antibody.
Pancreatic tissue, a target organ for CVB3 infection,
was found to have a large abundance of La protein
which was demonstrated to interact with the CVB3
5¢-UTR. Furthermore, exogenous addition of pan-
creas extract to in vitro translation reactions
resulted in a dose dependent stimulation of CVB3
IRES-mediated translation. These observations indi-
cate the role of La in CVB3 IRES-mediated transla-
tion, and suggest its possible involvement in the
ef®cient translation of the viral RNA in the pancreas.
INTRODUCTION
Internal initiation of translation, also referred to as cap-
independent translation, is fundamentally different from the
general cap-dependent scanning mechanism present in
eukaryotes (1). In the former mechanism the ribosome is
directly recruited to a site within the 5¢-untranslated region (5¢-
UTR) of the RNA and can initiate translation at the next
downstream AUG codon (2±4). The cis-acting RNA element
responsible for this internal ribosome binding is referred to as
the internal ribosome entry site (IRES). IRES-mediated
translation was ®rst discovered in the naturally uncapped
picornavirus RNAs (5,6), and later extended to some other
viruses like the Hepatitis C Virus (HCV) (7) and a number of
cellular mRNAs (8).
Coxsackievirus B3 (CVB3) is an important human patho-
gen and has been implicated as the leading cause of virus
induced myocarditis and dilated cardiomyopathy (9). Myo-
carditis induced by CVB3 in humans is a biphasic disease in
that an initial acute response occurs away from the heart
(mainly in the pancreas), and later a more chronic disease
spreads to the heart due to an autoimmune response against
cardiac proteins (10,11). The 741 nt 5¢-UTR of the CVB3
RNA is highly structured and contains eight AUG codons
upstream of the initiator AUG. The 5¢-UTR contains an IRES
that directs internal initiation of translation of the coding
region of the viral genome (12).
Ribosome binding to the IRES is mediated by an unknown
number of proteins, the majority of these being cellular
cytoplasmic proteins, as the infecting viral RNA is translated
prior to the production of any viral proteins. It is generally
believed that internal initiation by picornavirus IRESs requires
most of the canonical eukaryotic translation initiation factors
(eIFs) (13,14). However, as many picornaviruses (e.g.
Poliovirus and Coxsackievirus) induce the cleavage of the
eIF4G component of the tri-molecular eIF4F cap-binding
complex (15), it is clear that the requirement of IRES-
mediated translation for initiation factors is distinct from that
of general cap-dependent protein synthesis. In addition to the
canonical initiation factors, picornavirus IRES elements need
additional trans-acting factors for ef®cient translation initi-
ation. The proteins that have been found to interact with IRES
elements and stimulate translation are the human La
autoantigen (La), polypyrimidine-tract-binding protein
(PTB) (16,17), poly (rC)-binding protein 2 (PCBP2) (18),
unr and unrip (19).
The La protein was originally identi®ed as an autoantigen
that was recognized by sera from patients with systemic lupus
erythematosus and SjoÈgren syndrome (20). It is predominantly
localized within the nucleus and functions in the maturation of
RNA polymerase III transcripts (21,22) and the unwinding of
double-stranded RNA (23). It is present as 52 or 45 kDa
isoforms in different cell types (24). La antigen binds to a
variety of RNA structures via its RNA binding motif (25). The
viral targets of the La protein binding include the 5¢-UTR of
some picornaviruses (26), HCV (27), in¯uenza virus (28),
sindbis virus (29) and the HIV TAR element (30). In the case
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of poliovirus, the La protein plays a functional role in internal
initiation of translation where addition of puri®ed La to rabbit
reticulocyte lysate (RRL) inhibits the accumulation of aber-
rant translation products in in vitro translation assays and also
causes a modest stimulation of translation (31,32). La protein
has also been demonstrated to stimulate translation directed by
the IRES elements of Encephalomyocarditis virus (EMCV)
(33) and HCV (34). Sequestration of La protein by a small
yeast RNA (I-RNA) has been shown to inhibit poliovirus and
HCV IRES mediated translation, which could be rescued by
exogenous addition of puri®ed La protein (35±38). A similar
inhibition of HCV IRES-directed translation in HeLa lysates
has been demonstrated by sequestering La using a SELEX
RNA speci®c for La (34).
The present study was designed to investigate the involve-
ment of La protein in CVB3 IRES-mediated translation. We
show that human La protein binds to the CVB3 5¢-UTR and
demonstrate the dose-dependent effect of exogenously added
recombinant La in stimulating CVB3 IRES-mediated transla-
tion in vitro. A 60 nt yeast RNA (I-RNA) which has been
shown to bind to La protein (37) was used to sequester La in
in vitro translation assays to inhibit CVB3 IRES-mediated
translation which could be rescued by exogenous addition of
La protein. In order to investigate the activity of La from a
cellular source, abundance of La in various target tissues was
probed using La antibodies. The highest abundance of La
protein was found in the pancreas, a primary target organ of
CVB3. Therefore, exogenous addition of pancreatic extract to
in vitro translation reactions was carried out to explore its
ability to stimulate CVB3 IRES mediated translation. These
results constitute the ®rst report of the role of La in
Coxsackievirus B3 IRES-mediated translation and suggest
the possibility of its involvement in the ef®cient translation of
the viral RNA in the pancreas.
MATERIALS AND METHODS
Plasmid constructs
The 5¢-UTR of CVB3 was ampli®ed by PCR from the CVB3
full-length infectious cDNA (a generous gift from Prof. Nora
Chapman, UNMC) using 5¢ and 3¢ primers containing HindIII
and EcoRI sites, respectively, and cloned into the corresponding
sites of vector pCDNA3 (Invitrogen). The monocistronic
construct pCD-CVB 5¢-UTR±green ¯uorescent protein (GFP)
was constructed by cloning the GFP gene downstream of the
CVB3 5¢-UTR cloned in pCDNA3. The construct pCD±GFP
contained the GFP gene cloned in pCDNA3. The plasmid
pCDIR contains the 60 nt I-RNA coding synthetic oligo-
nucleotide sequence cloned in pCDNA3 under T7/CMV
promoters (a generous gift from Prof. Asim Dasgupta, UCLA;
36).
Preparation of HeLa S10 cell extract and mouse tissue
extracts
HeLa cells used for preparing cell extract were grown in
minimal essential medium (GIBCO BRL) pH 7.0, supple-
mented with 10% fetal calf serum. A monolayer of HeLa cells
was harvested, pelleted down and washed three times with
cold isotonic buffer (35 mM HEPES pH 7.4, 146 mM NaCl,
11 mM glucose), resuspended in 1.53 packed cell volume of
hypotonic buffer (10 mM HEPES pH 7.4, 15 mM KCl, 1.5 mM
Mg-acetate and 6 mM b-ME) and then incubated on ice for
10 min for swelling. Cells were then transferred to a Down's
Homogeniser and disrupted by 50 strokes on ice. The lysate
was incubated in 13 incubation buffer (103: 200 mM
HEPES, 1.2 M KCl, 50 mM Mg-acetate and 60 mM b-ME) for
10 min. Cytoplasmic extract (S10 supernatant) was isolated by
centrifuging the lysate at 10 000 g for 30 min at 4°C. The
supernatant was dialyzed for 2±4 h against 100 vol dialysis
buffer (10 mM HEPES, 90 mM KCl, 1.5 mM Mg-acetate,
7 mM b-ME, 20% glycerol).Various organs were carefully
dissected from 2-month-old Balb/c mice, minced and
resuspended in isotonic buffer. The samples were then
processed as mentioned above. The protein contents of the
tissue S10 extracts were estimated by Bradford's method
using a BSA standard curve.
Puri®cation of recombinant La protein
The cDNA encoding the human La antigen was PCR ampli®ed
from the plasmid pET-La (a generous gift from Prof. Jack
Keene, Duke University) and cloned into pRSET A vector
between BamHI and EcoRI sites and was used for the
expression of the recombinant La protein. The expression of
La was induced by 0.6 mM IPTG in Escherichia coli (BL21-
DE3) cells and the His-tagged protein was puri®ed using Ni2+-
nitrilotriacetic acid-agarose (Qiagen) under non-denaturing
conditions and eluted with 250 mM imidazole. The puri®ed
His-tagged La protein has an approximate molecular mass of
56.6 kDa.
In vitro transcription
mRNAs were transcribed in vitro from different linearized
plasmid constructs in run-off transcription reactions. The
clone pCD-CVB 5¢-UTR±GFP was linearized downstream of
GFP, eluted from agarose gels and then transcribed using T7
RNA polymerase to generate the monocistronic CVB 5¢-UTR-
GFP mRNA. The construct pCD±GFP was linearized and
transcribed in the presence of m7G(5¢)ppp(5¢)G RNA capping
analog (Gibco BRL) to generate capped GFP mRNA. The
construct pCDIR was linearized using EcoRI and transcribed
using T7 RNA polymerase to generate the 60 nt I-RNA. All
in vitro transcription reactions were carried out under standard
conditions using reagents from either Promega Corporation or
New England Biolabs, Inc. The pCD-CVB 5¢-UTR clone was
linearized, gel eluted and transcribed in vitro using T7 RNA
polymerase and [a-32P]UTP (NEN Co.) to generate the 32P-
labeled CVB full-length 5¢-UTR RNA. pGEM-3Z vector
DNA (Promega) was linearized with HindIII and transcribed
using T7 RNA polymerase to generate a 72 nt non-speci®c
RNA corresponding to the polylinker sequence.
In vitro translation
In vitro translation of the CVB 5¢-UTR±GFP mRNA was
carried out using 8.75 ml (200 mg) of micrococcal nuclease-
treated RRL medium (Promega), 0.5 ml of amino acid mixture
minus methionine, 20 mCi of 35S-methionine (NEN) and
supplemented with HeLa S10 where indicated. Puri®ed
recombinant La protein and pancreas S10 extract was added
to the reaction mixtures at various concentrations as indicated
in the results. In vitro transcribed I-RNA was added in
calculated molar quantities to reaction mixtures as indicated in
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the results of the inhibition and rescue experiments. The
reaction mixtures were incubated at 30°C for 90 min, and the
products were analyzed on SDS±12.5% polyacrylamide gels
followed by autoradiography or phosphorimaging (Fuji
Imaging).
UV crosslinking of proteins with RNA
Forty femtomoles (~10 ng) of in vitro transcribed 32P-labeled
CVB full-length 5¢-UTR RNA (741 nt) was incubated with
protein samples (HeLa cell extract, puri®ed La and Balb/c
mouse tissue extracts as indicated in Results) in 23 RNA
binding buffer [5 mM HEPES, 25 mM KCl, 2 mM MgCl2,
2 mM dithiothreitol (DTT), 0.1 mM EDTA, 3.8% glycerol,
1.5 mM ATP and 2 mM GTP] having 2 mg tRNA, for 30 min
and UV crosslinked by irradiation from a hand-held UV lamp.
For all the competition assays, competitor RNAs were added
along with the components of the reaction mixture before UV
cross linking. Unbound RNAs were digested by treatment with
30 mg of RNase A at 37°C for 30 min. The protein±
nucleotidyl complexes were run on SDS±12.5% polyacryl-
amide gels followed by autoradiography or phosphorimaging.
Immunoblotting
Various tissue extracts from Balb/c mice, containing equiva-
lent amounts of proteins (estimated by Bradford's method),
were suspended in equal volumes of 23 SDS gel-loading
buffer (100 mM Tris±Cl, 200 mM DTT, 4% SDS, 0.2%
bromophenol blue, 20% glycerol) and run on SDS±10%
polyacrylamide gel. Electro-transfer of proteins to nitrocellu-
lose membranes was carried out at 40 mA (constant) for 1.5 h
followed by immunoblotting using anti-La polyclonal anti-
bodies raised in rabbit (1:3000 titre). The membranes were
probed with horseradish peroxidase conjugated anti-rabbit
secondary antibodies (Bangalore Genei). Peroxidase activity
detection was carried out using Diaminobenzidine (Sigma-
Aldrich) and 3% H2O2 in PBS. A replica blot was probed with
mouse anti-actin antibodies (Santa Cruz Biotech) and anti-
mouse secondary antibodies followed by enhanced chemi-
luminescence (ECL) detection (Amersham-Pharmacia).
Immunoprecipitation
Pancreas and liver S10 extracts (50 mg of protein; 10 mg in
each of ®ve reactions) of Balb/c mice or HeLa S10 fraction
(72 mg of protein; 18 mg in each of four reactions) were mixed
with 32P-labeled CVB 5¢-UTR RNA in RNA binding buffer.
After UV crosslinking and RNase digestion, the reactions
were pooled together and the volume made up to 200 ml using
13 RIPA buffer (5 mM Tris±Cl pH 7.4, 150 mM NaCl, 1%
Triton-X100, 0.1% SDS, 1% sodium deoxycholate). Anti-La
polyclonal antibody or rabbit pre-immune serum was added
and incubated on ice for 4 h. The immunocomplexes were
precipitated by Protein A±CL Sepharose beads (Sigma-
Aldrich) for 2 h at 4°C. The beads were washed three times
with RIPA buffer. The bound proteins were analyzed by
SDS±10% polyacrylamide gel electrophoresis (PAGE)
followed by phosphorimaging.
RESULTS
CVB3 5¢-UTR binds to the La protein
The human La autoantigen has been reported to interact with
the IRES elements of poliovirus, EMCV and HCV. In order to
determine the binding of cellular proteins to the CVB3 5¢-
UTR, UV-crosslinking assay using 32P-labeled CVB full-
length 5¢-UTR RNA was performed with 9 mg HeLa S10
cellular extract. The CVB3 5¢-UTR showed strong interaction
with a number of cellular proteins from HeLa cytoplasmic
extract (Fig. 1A, lane 2) including a protein corresponding to
~52 kDa. This band may be that of the La antigen, which is
known to be abundant in HeLa cells. UV crosslinking between
full-length CVB3 5¢-UTR RNA and puri®ed, recombinant
His-tagged La protein demonstrated a strong interaction
(Fig. 1A, lane 3). To further con®rm the speci®c interaction
of La protein from HeLa cells with the CVB3 5¢-UTR,
immunoprecipitation of the nucleo±protein complexes formed
after UV crosslinking was performed using anti-La polyclonal
antibodies. The immunoprecipitation showed the presence of a
Figure 1. Speci®c interaction of La protein with the CVB3 5¢-UTR. (A) UV
crosslinking of 32P-labeled CVB3 5¢-UTR with 9 mg of HeLa S10 extract
(lane 2) and 400 ng of puri®ed His-La protein (lane 3). Lane 1 contains the
probe in absence of the added proteins. (B) CVB3 5¢-UTR±La UV-cross-
linked complexes with HeLa S10 (lanes 1 and 2) and puri®ed His-La
protein (lane 3) were immunoprecipitated using anti-La antibodies (lanes 1
and 3) and pre-immune rabbit serum (lane 2). The samples were resolved
by SDS±10% PAGE and the gels were exposed for phosphorimaging. Lane
M represents 14C-labeled protein markers. (A and B) The position of the
La±CVB3 RNA complex is indicated by arrows.
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CVB3 5¢-UTR±La complex of ~50±52 kDa from HeLa extract
(Fig. 1B, lane 1), corresponding in size to the protein band
observed in the UV crosslinking (Fig. 1A, lane 2). The
imunoprecipitated complex between CVB3 5¢-UTR RNA and
the His-tagged La protein (Fig. 1B, lane 3) showed slightly
higher migration than the endogenous La as also seen in the
UV-crosslinking experiment (Fig. 1A, lane 3). However, no
bands were observed upon immunoprecipitation using rabbit
pre-immune serum (Fig. 1B, lane 2). Therefore, CVB3 5¢-
UTR is found to interact speci®cally with both the HeLa
cellular and recombinant La proteins.
Dose-dependent effect of puri®ed La on CVB3
IRES-mediated translation in vitro
La protein has been demonstrated to stimulate translation
directed by the IRES elements of poliovirus, EMCV and HCV.
In order to examine the functional involvement of La in CVB3
IRES-mediated translation, an in vitro synthesized uncapped
CVB3 5¢-UTR±GFP RNA, in which the CVB3 IRES drives
the translation of the reporter gene GFP, was used as the
template. Increasing doses of puri®ed, recombinant La (90,
180, 300 and 450 ng) were exogenously added to the in vitro
translation reactions of CVB3 5¢-UTR±GFP. Similar quan-
tities of the recombinant protein were also added to translation
reactions having capped GFP RNA as the template. The
results showed that exogenous addition of La to RRL was
able to signi®cantly stimulate the ef®ciency of CVB3
IRES-mediated translation (Fig. 2A). The effect of La was
quite pronounced (~7-fold increase in reporter gene transla-
tion) as seen from quanti®cation of the intensities of the
translated protein bands. However, the level of translation was
slightly reduced from the maximum level upon addition of the
highest dose (450 ng) of La protein. No signi®cant increase
was observed upon addition of similar concentrations of La on
the cap-dependent translation of GFP (Fig. 2B). These
observations indicate the functional involvement of the La
protein in CVB3 IRES-mediated translation.
La protein binding to the CVB3 5¢-UTR can be
competed out by a small RNA (I-RNA)
A 60 nt RNA originally isolated from the yeast Saccharo-
myces cerevisae (I-RNA) has been shown to bind to La protein
(37) and also to compete ef®ciently with the poliovirus 5¢-
UTR for binding to HeLa cellular La antigen. In order to
determine whether the I-RNA can compete with the CVB3
IRES for binding to puri®ed La protein, competition UV-
crosslinking assays were performed using radiolabeled CVB3
5¢-UTR RNA and increasing concentrations of unlabeled
I-RNA as the competitor RNA.
The result showed that the amount of La protein bound to
the CVB3 5¢-UTR reduced in a gradual manner on addition of
increasing molar concentrations of in vitro transcribed I-RNA
(200-, 400- and 600-fold excess) as indicated by the reduction
in the intensity of the La protein±nucleotidyl complex band
(Fig. 3A, lanes 1±4). This points to the fact that I-RNA is able
to successfully compete out the CVB3 5¢-UTR from its
Figure 2. Stimulation of CVB3 IRES mediated translation of GFP in RRL by His-tagged La protein. (A) Representative translation of in vitro transcribed
uncapped CVB3 5¢-UTR±GFP RNA in RRL supplemented with increasing amounts of puri®ed La protein (as indicated above the panel). (B) Translation of
in vitro transcribed, capped GFP RNA in presence of the same increasing concentrations of La protein. The translation reactions were carried out using ~1 mg
of RNA template. The gels were treated with 1 M sodium salicylate, dried and exposed for phosphorimaging. Intensities of GFP bands in the translation
reactions were quanti®ed by Fuji Imagegauge and are graphically represented below each panel.
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binding with La protein. However, 400- and 600-fold molar
excess of a non-speci®c RNA (72 nt long), when added to the
binding reaction, was unable to compete with the CVB3
5¢-UTR for La binding (Fig. 3B, lanes 1±3).
Inhibition of CVB3 IRES-mediated translation by
I-RNA and rescue by La protein
I-RNA, which can bind to the La protein, has been shown to be
able to selectively block translation initiation directed by
poliovirus (35,36) and HCV IRESs (38). Moreover, I-RNA-
mediated inhibition of translation directed by poliovirus and
HCV IRESs in HeLa S10 extract was rescued by exogenous
addition of puri®ed La protein (35,37). In order to investigate
the necessity of La protein for CVB3 IRES-mediated trans-
lation, 2 mg (50-fold excess) of I-RNA was added to the in vitro
translation reaction of CVB3 5¢-UTR±GFP in RRL supple-
mented with 500 ng of HeLa S10 extract. The supplementation
of the reaction medium with HeLa cytoplasmic extract was
necessitated by the very low basal levels of translation
directed by the CVB3 5¢-UTR in RRL which is enhanced by
addition of HeLa extract. It was observed that the translation
of GFP directed by the CVB3 IRES was drastically reduced by
the addition of I-RNA (Fig. 3C, lane 2). In order to examine
the ability of La protein to rescue the I-RNA-mediated
inhibition of translation, increasing concentrations (200 and
400 ng) of recombinant La protein were added to the in vitro
translation reactions in presence of the same quantities of
I-RNA. It was observed that the CVB3 IRES-mediated
translation was restored by La protein in a dose-dependent
manner (Fig. 3C, lanes 3 and 4) to the original level. The data
suggest that inhibition of CVB3 IRES-mediated translation by
I-RNA was primarily due to the sequestration of La protein
and La is necessary for CVB3 IRES-mediated translation.
Moreover, addition of La protein is suf®cient to rescue the
I-RNA-mediated inhibition of the CVB3 IRES-directed
translation in RRL.
La protein is present at variable levels in different
tissues
La is a cellular autoantigen that has been shown to be present
in different tissues predominantly as 52 or 45 kDa isoforms.
La antigen-encoding mRNA transcripts also exhibit a tissue-
speci®c expression pattern, with a 1.9 kb transcript being
ubiquitously expressed in human tissues and a 2.3 kb
transcript which is expressed at high levels in spleen, PBL,
brain, kidney and pancreas (39). Although the extent of
difference between the protein products of these transcripts is
not known, it has been suggested that the 1.9 kb transcript is
predominantly translated by a cap-dependent scanning
mechanism while the 2.3 kb transcript undergoes internal
initiation (39). In order to detect the presence and relative
abundance of La protein in various mouse tissues, western
blotting of equal quantities of total cytoplasmic protein from
these tissues was performed using polyclonal anti-La anti-
bodies. Mouse tissue cytoplasmic extracts were used for the
experiment because the course of CVB3 infection in the
murine disease model is same as that in humans (10). The
immunoblot showed that the relative abundance of the La
protein, corresponding to a band of ~45 kDa, was highest in
pancreas, followed by spleen, kidney and brain tissue extracts
(Fig. 4). A corresponding faint band was detectable in the
heart extract but was undetected in liver. A replica blot was
also probed with anti-b actin antibody as internal control.
These observations suggest that the abundance of the La
protein is different in the different tissues tested and is
relatively high in the pancreas.
Figure 3. Competition of I-RNA with CVB3 5¢-UTR for binding to La and
rescue of CVB3 IRES-mediated translation by recombinant La protein.
(A) [32P]UTP labeled CVB3 5¢-UTR RNA probe was UV crosslinked to
His-tagged La protein in the absence (lane 1) and presence (lanes 2±4) of
200-, 400- and 600-fold molar excess of unlabeled I-RNA. (B) [32P]UTP
labeled CVB3 5¢-UTR RNA probe was UV crosslinked to His-tagged La
protein in the absence (lane 1) and presence (lanes 2 and 3) of 400- and
600-fold molar excess of a non-speci®c RNA. (C) CVB3 5¢-UTR±GFP
RNA was translated in vitro in RRL supplemented with 0.5 mg HeLa S10
(lanes 1±4), 50-fold excess of I-RNA (lanes 2±4) and two concentrations
(200 and 400 ng) of La protein (lanes 3 and 4). The positions of the
La±CVB3 RNA complex (A and B) and the translation product GFP (C) are
indicated by arrows.
Figure 4. Immunoblot of mouse tissue extracts using anti-La polyclonal
antibodies. Various mouse tissue extracts (as indicated) containing equiva-
lent amounts of total protein were resolved on SDS±10% PAGE and probed
with polyclonal anti-La antibody. After probing with HRP-conjugated
secondary antibody, immunoreactive bands were visualized by peroxidase
reaction using diaminobenzidine as substrate. A replica blot containing the
same amounts of protein per lane was probed with anti-b actin monoclonal
antibody and anti-mouse secondary antibody followed by ECL.
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CVB3 5¢-UTR speci®cally interacts with La protein from
the mouse pancreas
CVB3, like other enteroviruses, ®rst enters through the small
intestine and then infects adjacent organs, mainly the
pancreas, and later spreads to other sites like the heart. The
pancreas serves as the viral reservoir. The ef®cient propaga-
tion of CVB3 in the pancreas may be due to the presence of
tissue-speci®c factors, like the La protein, which enhances
virus translation/replication in vivo. As the La protein was
found to be abundant in the pancreatic tissue, we investigated
the ability of the cellular La protein to interact with the CVB3
5¢-UTR RNA by UV crosslinking assay followed by
immunoprecipitation.
The UV crosslinking showed a number of proteins from the
pancreas cytoplasmic extract binding to the CVB3 5¢-UTR. A
prominent RNA±protein complex, corresponding to ~45 kDa
was observed (Fig. 5A, lane 2). The other protein±nucleotidyl
complexes may correspond to various trans-acting factors
including PTB (p57/p60) and PCBP2 (39 kDa), which may
also interact with the CVB3 5¢-UTR.
To con®rm the interaction of the cellular La protein with the
CVB3 5¢-UTR, the UV-crosslinked CVB3 5¢-UTR RNA±
protein complex from pancreas was immunoprecipitated using
anti-La antibodies. A complex of CVB3 5¢-UTR RNA and La
was observed (Fig. 5B, lane 2) upon UV crosslinking followed
by immunoprecipitation with anti-La antibodies but not with
pre-immune rabbit serum (Fig. 5B, lane 1). However,
immunoprecipitation of CVB3 5¢-UTR RNA±protein com-
plexes from liver extract of mouse, using anti-La antibodies,
did not show any speci®c band (Fig. 5D, lane 2). These results
were consistent with the observation in the western blot and
suggest a speci®c interaction between the CVB3 IRES and La
protein from mouse pancreas. Similar La protein±nucleotidyl
complexes were observed upon immunoprecipitation of
spleen and brain tissue extracts after UV crosslinking with
CVB3 5¢-UTR RNA (data not shown).
Effect of exogenous addition of mouse pancreas
cytoplasmic extract on CVB3 IRES-mediated translation
The pancreas serves as the primary site of infection by CVB3
and is also a major target organ for CVB3-mediated
pathogenesis. As we found that the La protein was required
for translation directed by the CVB3 IRES, and the abundance
of La was greatest in the pancreatic tissue, we wanted to
examine the ability of pancreatic tissue extract to stimulate the
translation directed by the CVB3 IRES. Therefore, in vitro
translation reactions in RRL using CVB3 5¢-UTR±GFP RNA
as the template were supplemented by S10 extracts of the
pancreas of Balb/c mice at two increasing concentrations. The
results showed that addition of pancreas extract stimulated the
translation of the reporter gene GFP in a concentration-
dependent manner above the basal level (Fig. 6A). The higher
concentration of the tissue extract was also added to transla-
tion reactions having capped-GFP RNA as the template.
However, addition of the pancreatic extract did not exhibit an
enhancement of cap-dependent translation (Fig. 6A, right),
rather a slight reduction in the translation ef®ciency was
observed. These observations suggest that the ef®ciency of the
CVB3 IRES-mediated translation in pancreatic tissue is high
and this may be correlated to the high concentration of La
protein in the tissue.
In order to determine whether the stimulation in translation
observed upon addition of pancreas extract could be abrogated
by sequestering the La protein, 20- and 40-fold excess of
I-RNA was added to the in vitro translation reactions
supplemented with pancreas cytoplasmic extract (Fig. 6B,
lanes 2±6). A signi®cant dose-dependent reduction in the
translation ef®ciency was observed (Fig. 6B, lanes 4 and 5),
suggesting that I-RNA can inhibit the translation mediated by
the CVB3 IRES in presence of pancreas extract. Furthermore,
to investigate whether the I-RNA mediated inhibition was due
to the sequestration of the La protein from pancreas extract,
Figure 5. Interaction of CVB3 5¢-UTR RNA with La protein from mouse
pancreas. (A) 32P-labeled CVB3 5¢-UTR RNA was UV crosslinked to pan-
creas cytoplasmic extract of Balb/c mice (lane 2). Lane 1 contains the free
probe in the absence of any added proteins. (B) 32P-labeled CVB3 5¢-UTR
RNA±protein complexes from the pancreas extract were immunoprecipi-
tated using anti-La antibodies (lane 2) and pre-immune serum (lane 1).
(C and D) UV crosslinking and immunoprecipitation of 32P-labeled CVB3
5¢-UTR RNA±protein complexes from liver cytoplasmic extract of Balb/c
mice. Lanes 1 and 2 correspond to those in (A) and (B). Lane 3 in (D) con-
tains puri®ed His-tagged La protein immunoprecipitated with anti-La anti-
bodies. The samples were resolved by SDS±10% PAGE, the gels were dried
and exposed for phosphorimaging. Lane M represents 14C-labeled protein
markers. The arrow indicates CVB3 5¢-UTR RNA±La complex.
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600 ng of recombinant La protein was added to the translation
reaction supplemented with pancreas extract in presence of
40-fold excess of I-RNA. It was observed that the addition of
La protein could restore the translation ef®ciency to original
levels (Fig. 6B, lane 6). Taken together, these observations
suggest that La protein is required for CVB3 IRES-mediated
translation and may be an important trans-acting factor
present in the pancreas, which enhances the ef®ciency of
Coxsackievirus IRES-mediated translation in the organ.
DISCUSSION
A growing body of evidence suggests that internal initiation of
translation by picornaviruses and cellular mRNAs is a
phenomenon mediated by speci®c interactions between
cis-elements on the RNA (the IRES) and various trans-acting
factors. These factors required for internal initiation are
thought to be proteins from the host cell cytoplasm. However,
the functional role of these proteins in IRES-mediated
translation is not known although a function as RNA
chaperones has been proposed. Studies on these IRES-
interacting cellular proteins hold the promise of explaining
the differential translation ef®ciency of the viral RNA in
different tissues. It has been seen that in transient expression
assays, the ef®ciency of different IRES elements varies greatly
in different cell types (40,41). Hence, the translational
ef®ciency of these IRES elements must be in¯uenced by
cellular trans-acting factors. Indeed, the neurovirulence of
wild-type poliovirus is dependent on recognition of poliovirus
IRES within neuronal cells, whereas the IRES of vaccine
strains function poorly in these cells (13). It has also been
reported that tissue-speci®c expression of PTB and nPTB
(neuronal isoform) is an important determinant of cell-speci®c
translational control and neurovirulence of Theiler's murine
encephalitis virus (42).
The CVB3 receptor (coxsackie and adenovirus receptor) is
known to be present on most tissues in the body (43) but the
virus infects speci®c organs like the heart, pancreas, brain and
spleen. Therefore, phenomena like host tissue speci®city may
be explained as a complex interplay of cellular surface
receptors and intracellular trans-acting factors in¯uencing
translation/replication of the virus (44). The only protein that
has been reported to interact with the CVB3 5¢-UTR and
in¯uence the IRES-mediated translation is PCBP2 (45).
Our observations show that the human La antigen speci®c-
ally interacts with the CVB3 5¢-UTR containing the IRES
element and stimulates CVB3 IRES-mediated translation, as is
also seen in the case of poliovirus and HCV. The basal level of
translation directed by the CVB3 IRES in RRL, which has
limiting quantities of La, is low. Therefore, the stimulatory
effect of La is quite pronounced. The slight reduction in the
translation level on adding higher quantities of La may be due
to the non-speci®c RNA±protein interactions at high concen-
trations of added protein, which may prevent the binding of
other canonical and non-canonical translation factors.
Our experiments with I-RNA, which has been reported to
bind to the La protein, demonstrated that I-RNA can compete
with the CVB3 5¢-UTR for binding to La and can also inhibit
CVB3 IRES-directed translation. This suggests that I-RNA
sequesters the La protein from the HeLa S10 supplemented
RRL and, thus, prevents its interaction with the CVB3 IRES.
This inhibition could be abolished by exogenous addition of
La protein, which restored the translation ef®ciency to the
original levels. This indicates that La protein is necessary for
ef®cient translation initiation directed by the CVB3 IRES.
Although the I-RNA is known to bind to other cellular proteins
and may also sequester them, addition of La protein alone was
suf®cient to rescue the I-RNA-mediated inhibition of trans-
lation directed by the CVB3 IRES. It is possible that the other
proteins, which bind to the I-RNA (46), may not be as critical
for the CVB3 IRES-mediated translation. Alternatively, the
Figure 6. Effect of exogenously added mouse pancreas extract on CVB3
IRES-mediated translation. (A) Two increasing doses of pancreas extract
from Balb/c mice were exogenously added to in vitro translation reactions
of CVB3 5¢-UTR±GFP RNA in RRL (lanes 2 and 3). Approximately 1 mg
of RNA template was used in each reaction. The higher dose of the pan-
creas extract was added to in vitro translation reaction using capped GFP
RNA as template (lane 5). Control lanes (lanes 1 and 4) indicate translation
of RNA templates in the absence of any supplementation. (B) Two increas-
ing doses of pancreas extract (lanes 2 and 3) were added to in vitro transla-
tion reactions of CVB3 5¢-UTR±GFP in RRL. Approximately 2 mg of RNA
template was used in each reaction. In the presence of the higher dose of
pancreas extract, 20- and 40-fold excess of I-RNA (lanes 4 and 5) was
added to the reaction medium. In the presence of the higher dose of the pan-
creas extract and the 40-fold excess of I-RNA, 600 ng of puri®ed La protein
was added to the reaction mixture (lane 6). The GFP bands are indicated by
arrows. The GFP band intensities were quanti®ed and are represented
graphically below each panel.
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binding of La to the CVB3 IRES facilitates its interaction with
other trans-acting factors. This might also be the reason why a
lower concentration of I-RNA (50-fold excess) is able to
inhibit CVB3 IRES-mediated translation by sequestering La
and preventing these interactions, although a larger amount
(600-fold excess) is needed to compete out the binding of La
with the CVB3 5¢-UTR. This observation is consistent with
earlier reports where I-RNA-mediated inhibition of poliovirus
and HCV IRES-driven translation was reversed by the
exogenous addition of puri®ed La protein alone. Moreover,
the amount of La protein required to rescue the CVB3 IRES
mediated translation is comparable with the levels required for
rescuing the translation directed by the poliovirus IRES (35).
In an attempt to identify the major cellular sources of La
protein, immunblotting of various tissue cytoplasmic extracts
from Balb/c mouse was performed using anti-La antibodies
which demonstrated the presence of the protein at variable
levels in various tissues. Interestingly, the maximum concen-
tration of the La protein was found in the pancreas extract. La
mRNA has been shown to be present at different levels in
various organs and some of the organs exhibiting high levels
of the La mRNA, like the pancreas, spleen and the brain, were
also found to have high levels of the protein. These organs,
most importantly the pancreas, also serve as target organs of
CVB3. Moreover, it has been suggested that a speci®c spliced
form of the La mRNA (La 1¢) is translated more ef®ciently in a
cap-independent manner (39) and will, therefore, continue to
be translated upon CVB3 infection, when cap-dependent
translation has been shut down due to the cleavage of cellular
eIF4G. Surprisingly, the level of La protein was found to be
very low in the heart tissue cytoplasmic extract in the
immunoblot. However, it should be mentioned that La is
predominantly a nuclear protein and, in the case of poliovirus
infection, major amounts of the protein are localized to the
cytoplasm only on cleavage of the nuclear localization signal
by viral 3C-protease (47). The recruitment of the nuclear-
localized La protein in heart tissue after infection by CVB3
may be of major importance to the propagation of the virus in
the heart. On the other hand, the cytoplasmic levels of La
would normally be crucial for viral translation because the
viral genome has to be initially translated post-infection, in
order to synthesize the virus-encoded proteins, and this
translation would be dependent on the cytoplasmic pool of
the La protein. It has also been reported that cells stably
expressing the La 1¢ mRNA showed a predominantly
cytoplasmic localization of the La protein, whereas those
expressing the alternately spliced La 1 mRNA showed a
nuclear localization of the protein (48).
The La protein, demonstrated to be present in the pancreatic
extract, was also found to interact speci®cally with the CVB3
5¢-UTR RNA. The pancreas is now thought to be the primary
site of CVB3 infection and the viral reservoir. Therefore, the
ef®ciency of translation of the viral RNA in the pancreas, post
infection, would play a crucial role in the ability of the virus to
propagate in the tissue. It has been demonstrated that
transgenic mice expressing IFN-g under the in¯uence of the
insulin promoter in the pancreatic b cells does not allow CVB3
replication in the pancreas. These mice failed to develop
myocarditis after being infected by the virus although there
was no expression of IFN-g in the heart tissue (10). Therefore,
the translation/replication of CVB3 RNA within the pancreas
will be of great importance to the survival and propagation of
the virus. The translation ef®ciency in pancreatic tissue may
be in¯uenced by the presence of high amounts of La protein,
which was found to be crucial for the enhancement of CVB3
IRES-mediated translation in vitro. Accordingly, it was
observed that cytoplasmic extract from the pancreas was
able to enhance the CVB3 IRES-mediated translation in a
dose-dependent manner. Previously, it has been reported that
the exogenous addition of liver cytoplasmic extract was able
to enhance the translation mediated by the Hepatitis A virus
IRES in RRL, although the stimulation was not attributed to
any speci®c trans-acting factor (49). However, the stimulation
in CVB3 IRES-mediated translation, which is observed on
addition of pancreas extract, is abrogated on addition of excess
of I-RNA, which is known to bind to La protein and which can
inhibit the translation driven by the CVB3 IRES in RRL
medium supplemented with HeLa cytoplasmic extract.
Moreover, the translation ef®ciency can be restored on
addition of excess puri®ed La protein to the reaction medium.
This seems to reinforce the idea that La protein plays an
important role in the stimulation of CVB3 IRES-mediated
translation by pancreatic tissue extract and possibly in the
virus proliferation in the tissue.
This study constitutes the ®rst report of the involvement of
La in CVB3 IRES-mediated translation. It demonstrates the
necessity of La protein for the process of internal initiation by
the CVB3 IRES and also forwards the possibility that the
presence of an abundance of La protein is correlated to
ef®cient viral translation in a major target organ, namely the
pancreas. It would be of interest to see how the presence of
speci®c trans-acting factors is able to regulate CVB3 IRES-
mediated translation and virus proliferation in various tissues.
Further studies involving identi®cation of such tissue-speci®c
factors will help elucidate the mechanism of IRES-mediated
translation of the CVB3 RNA and may provide new targets for
anti-viral therapeutics.
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